Although qRT-PCR is the standard test for detecting BCR::ABL of CML, it has limits in the breakpoints detected based on the location of the primers and probes.[21] Therefore, further sanger sequencing and FISH were needed in order to verify our result. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.